Lupin分了自己的消费者保健部,Lupin Life, 集中关注处方药。 Lupin splits off its consumer healthcare division, LupinLife, to focus on prescription drugs.

印度制药公司Lupin从7月1日起将消费者保健业务LupinLupinLupinLupinLife消费者保健转成一个独立的实体。 Indian pharmaceutical company Lupin is spinning off its consumer healthcare business, LupinLife Consumer Healthcare, into a separate entity starting July 1. 此举旨在使Lupin能够侧重于其核心处方药物业务,同时为其消费者保健司提供更好的增长机会,后者在24财政年度的收入约为148克朗。 This move aims to allow Lupin to focus on its core prescription drug business while providing better growth opportunities for its consumer healthcare division, which had revenues of about ₹148 crore in FY24. 该新实体将由Sanjeev Jain领导。 The new entity will be led by Sanjeev Jain.